Monoamine oxidase inhibitors : new developments. SymposiumPAYKEL, Eugene S; YOUDIM, Moussa B. H.Clinical neuropharmacology. 1993, Vol 16, issn 0362-5664, SUP2Conference Proceedings

Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugsMANDEL, Silvia; WEINREB, Orly; YOUDIM, Moussa B. H et al.Drug discovery today. 2004, Vol 9, Num 24, pp 37-44, issn 1359-6446, 8 p., SUPArticle

Monoamine oxidase : isoforms and inhibitors in Parkinson's disease and depressive illnessYOUDIM, Moussa B. H; BAKHLE, Y. S.British journal of pharmacology. 2006, Vol 147, issn 0007-1188, S287-S296, SUP1Article

Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behavioursFINBERG, John P. M; YOUDIM, Moussa B. H.Neuropharmacology. 2002, Vol 43, Num 7, pp 1110-1118, issn 0028-3908, 9 p.Article

The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in ratsSAGI, Yotam; DRIGUES, Noam; YOUDIM, Moussa B. H et al.British journal of pharmacology. 2005, Vol 146, Num 4, pp 553-560, issn 0007-1188, 8 p.Article

Novel neuroprotective anti-Alzheimer drugs with anti-depressant activity derived from the anti-Parkinson drug, rasagiline : Interventions, Part IIIYOUDIM, Moussa B. H; WEINSTOCK, Marta.Mechanisms of ageing and development. 2002, Vol 123, Num 8, pp 1081-1086, issn 0047-6374Conference Paper

Site-Activated Multifunctional Chelator with Acetylcholinesterase and Neuroprotective— Neurorestorative Moieties for Alzheimer's TherapyHAILIN ZHENG; YOUDIM, Moussa B. H; FRIDKIN, Mati et al.Journal of medicinal chemistry (Print). 2009, Vol 52, Num 14, pp 4095-4098, issn 0022-2623, 4 p.Article

Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitorSAGI, Yotam; WEINSTOCK, Marta; YOUDIM, Moussa B. H et al.Journal of neurochemistry. 2003, Vol 86, Num 2, pp 290-297, issn 0022-3042, 8 p.Article

Neurotransmitter actions and interactions, Algarve, Portugal, April 29-30, 1989YOUDIM, Moussa B. H; TIPTON, Keith F.Journal of neural transmission. Supplementum. 1990, Num 29, pp X-304, issn 0303-6995, p. [314 p.]Conference Proceedings

Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitroBAR-AM, Orit; AMIT, Tamar; YOUDIM, Moussa B. H et al.Journal of neurochemistry. 2007, Vol 103, Num 2, pp 500-508, issn 0022-3042, 9 p.Article

Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegilineAM, Orit Bar; AMIT, Tamar; YOUDIM, Moussa B. H et al.Neuroscience letters. 2004, Vol 355, Num 3, pp 169-172, issn 0304-3940, 4 p.Article

A Novel Iron-Chelating Derivative of the Neuroprotective Peptide NAPVSIPQ Shows Superior Antioxidant and Antineurodegenerative CapabilitiesBLAT, Dan; WEINER, Lev; YOUDIM, Moussa B. H et al.Journal of medicinal chemistry (Print). 2008, Vol 51, Num 1, pp 126-134, issn 0022-2623, 9 p.Article

Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletionGAL, Shunit; HAILIN ZHENG; FRIDKIN, Mati et al.Journal of neurochemistry. 2005, Vol 95, Num 1, pp 79-88, issn 0022-3042, 10 p.Article

Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (KF-κB) activation and cell death by tea extracts in neuronal culturesLEVITES, Yona; YOUDIM, Moussa B. H; MAOR, Gila et al.Biochemical pharmacology. 2002, Vol 63, Num 1, pp 21-29, issn 0006-2952Article

Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase BYOUDIM, Moussa B. H; GROSS, Aviva; FINBERG, John P. M et al.British journal of pharmacology. 2001, Vol 132, Num 2, pp 500-506, issn 0007-1188Article

Development of a novel neuroprotective drug (TV3326) for the treatment of Alzheimer's disease, with cholinesterase and monoamine oxidase inhibitory activitiesWEINSTOCK, Marta; GOREN, Tamar; YOUDIM, Moussa B. H et al.Drug development research. 2000, Vol 50, Num 3-4, pp 216-222, issn 0272-4391Article

Effect of TV3326, a novel monoamine-oxidase cholinesterase inhibitor, in rat models of anxiety and depressionWEINSTOCK, Marta; POLTYREV, Tatyana; BEJAR, Corina et al.Psychopharmacologia. 2002, Vol 160, Num 3, pp 318-324, issn 0033-3158Article

Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphineGRÜNBLATT, Edna; MANDEL, Silvia; MAOR, Gila et al.Journal of neurochemistry. 2001, Vol 78, Num 1, pp 1-12, issn 0022-3042Article

Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseasesMANDEL, Silvia; WEINREB, Orly; AMIT, Tamar et al.Journal of neurochemistry. 2004, Vol 88, Num 6, pp 1555-1569, issn 0022-3042, 15 p.Article

A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's diseaseYOUDIM, Moussa B. H; RIEDERER, Peter F.Neurology. 2004, Vol 63, Num 7, pp S32-S35, issn 0028-3878, SUP2Article

The therapeutic potential of monoamine oxidase inhibitorsYOUDIM, Moussa B. H; EDMONDSON, Dale; TIPTON, Keith F et al.Nature reviews. Neuroscience (Print). 2006, Vol 7, Num 4, pp 295-309, issn 1471-003X, 15 p.Article

Gene expression changes in peripheral mononuclear cells from schizophrenic patients treated with a combination of antipsychotic with fluvoxamineCHENKOW, Yael; WEINREB, Orly; YOUDIM, Moussa B. H et al.Progress in neuro-psychopharmacology & biological psychiatry. 2007, Vol 31, Num 7, pp 1356-1362, issn 0278-5846, 7 p.Article

Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseasesWEINREB, Orly; MANDEL, Silvia; AMIT, Tamar et al.Journal of nutritional biochemistry. 2004, Vol 15, Num 9, pp 506-516, issn 0955-2863, 11 p.Article

Chronic treatment with serotonin reuptake inhibitor antidepressant (SSRI) combined with an antipsychotic regulates GABA-A receptor in rat prefrontal cortexDANOVICH, Lena; WEINREB, Orly; YOUDIM, Moussa B. H et al.Psychopharmacologia. 2012, Vol 220, Num 4, pp 763-770, issn 0033-3158, 8 p.Article

Green tea polyphenol (-)-epigallocatechin-3-gallate promotes the rapid protein kinase C-and proteasome-mediated degradation of Bad : implications for neuroprotectionKALFON, Limor; YOUDIM, Moussa B. H; MANDEL, Silvia A et al.Journal of neurochemistry. 2007, Vol 100, Num 4, pp 992-1002, issn 0022-3042, 11 p.Article